These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 34287992)

  • 41. Rezūm water vapor therapy in multimorbid patients with urinary retention and catheter dependency.
    Eredics K; Wehrberger C; Henning A; Sevcenco S; Marszalek M; Rauchenwald M; Falkensammer C; Stoces U; Madersbacher S; Horetzky M; Kunit T; Lusuardi L
    Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):302-305. PubMed ID: 34588631
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up.
    Porpiglia F; Fiori C; Amparore D; Kadner G; Manit A; Valerio M; Nicolaas L; Ho BSH; Alonso S; Schulman C; Barber N
    BJU Int; 2019 Jun; 123(6):1061-1069. PubMed ID: 30382600
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medium-Term Real-World Outcomes of Minimally Invasive Surgical Therapies for Benign Prostatic Hyperplasia: Water Vapor Thermal Therapy (Rezum)
    Chin CP; Garden EB; Ravivarapu KT; Shukla D; Omidele O; Levy M; Qian D; Araya JS; Valenzuela R; Reddy A; Marshall S; Motola J; Nobert C; Gupta M; Small AC; Kaplan SA; Palese MA
    J Endourol; 2022 Dec; 36(12):1559-1566. PubMed ID: 36039926
    [No Abstract]   [Full Text] [Related]  

  • 44. Water vapor thermal therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: Systematic review and meta-analysis.
    Miller LE; Chughtai B; McVary K; Gonzalez RR; Rojanasarot S; DeRouen K; Bhattacharyya S
    Medicine (Baltimore); 2020 Jul; 99(30):e21365. PubMed ID: 32791742
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rezum to the rescue: Early outcomes of Rezum on patients with recurrent lower urinary tract symptoms after surgical interventions for benign prostatic enlargement.
    Gauhar V; Lim EJ; Khan TY; Law YXT; Choo ZW; Castellani D; Teoh JY; Bhojani N; Chughtai B; Zorn K; Elterman D
    Andrologia; 2022 Sep; 54(8):e14450. PubMed ID: 35474587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Water vapor thermal therapy to alleviate catheter-dependent urinary retention secondary to benign prostatic hyperplasia.
    McVary KT; Holland B; Beahrs JR
    Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):303-308. PubMed ID: 31740738
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The efficacy of additive tolterodine extended release for 1-year in older men with storage symptoms and clinical benign proastatic hyperplasia.
    Chung SD; Chang HC; Chiu B; Liao CH; Kuo HC
    Neurourol Urodyn; 2011 Apr; 30(4):568-71. PubMed ID: 21344494
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prospective comparison of greenlight laser anatomic vaporization-incision technique and photoselective vaporization of the prostate in the treatment of benign prostatic hyperplasia].
    Hu GM; Yan YH; Xu M; Liu XL; Tao W; Xue BX
    Zhonghua Yi Xue Za Zhi; 2022 Jan; 102(4):267-272. PubMed ID: 35073675
    [No Abstract]   [Full Text] [Related]  

  • 49. Efficacy, Safety, and Durability of 532 nm Laser Photovaporization of the Prostate with GreenLight 180 W XPS in Men with Acute Urinary Retention.
    Goueli R; Meskawi M; Thomas D; Hueber PA; Tholomier C; Valdivieso R; Te A; Zorn KC; Chughtai B
    J Endourol; 2017 Nov; 31(11):1189-1194. PubMed ID: 28844169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical, laboratorial, and urodynamic findings of prostatic artery embolization for the treatment of urinary retention related to benign prostatic hyperplasia. A prospective single-center pilot study.
    Antunes AA; Carnevale FC; da Motta Leal Filho JM; Yoshinaga EM; Cerri LM; Baroni RH; Marcelino AS; Cerri GG; Srougi M
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):978-86. PubMed ID: 23580116
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Minimally invasive connective water vapor energy method for benign prostatic hyperplasia.
    Çakıroğlu B
    Urologia; 2024 May; 91(2):298-305. PubMed ID: 38069654
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Durability of 30-minute high-energy transurethral microwave therapy for treatment of benign prostatic hyperplasia: a study of 213 patients with and without urinary retention.
    Gravas S; Laguna P; Kiemeney LA; de la Rosette JJ
    Urology; 2007 May; 69(5):854-8. PubMed ID: 17482921
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microwave thermotherapy for benign prostatic hyperplasia.
    Hoffman RM; Monga M; Elliott SP; Macdonald R; Langsjoen J; Tacklind J; Wilt TJ
    Cochrane Database Syst Rev; 2012 Sep; (9):CD004135. PubMed ID: 22972068
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparative randomized prospective study to evaluate efficacy and safety of combination of tamsulosin and tadalafil vs. tamsulosin or tadalafil alone in patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
    Singh DV; Mete UK; Mandal AK; Singh SK
    J Sex Med; 2014 Jan; 11(1):187-96. PubMed ID: 24165272
    [TBL] [Abstract][Full Text] [Related]  

  • 55. What's New in Rezum: a Transurethral Water Vapour Therapy for BPH.
    Green Z; Westwood J; Somani BK
    Curr Urol Rep; 2019 May; 20(7):39. PubMed ID: 31152253
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predicting the risk of failed trial without catheter following Rezum™ therapy.
    Coscarella M; Al Barajraji M; Moussa I; Hombert L; Naudin M; Roumeguère T
    World J Urol; 2024 Mar; 42(1):129. PubMed ID: 38460028
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Photoselective laser vaporization prostatectomy for acute urinary retention in China.
    Fu WJ; Gao JP; Hong BF; Yang Y; Cai W; Zhang L
    J Endourol; 2008 Mar; 22(3):539-43. PubMed ID: 18355150
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Head-to-head comparison of prostatic urethral lift and water vapor thermal therapy for the treatment of symptomatic benign prostatic hyperplasia: a real-life study.
    Baboudjian M; Fourmarier M; Gondran-Tellier B; Pradere B; Userovici M; Alegorides C; Barry Delongchamps N
    Int Urol Nephrol; 2021 Sep; 53(9):1757-1763. PubMed ID: 34052957
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of a vaporization-resection of the prostate median lobe enlargement and vaporization of the prostate lateral lobe for benign prostatic hyperplasia using a 120-W GreenLight high-performance system laser: the effect on storage symptoms.
    Kim KS; Choi SW; Bae WJ; Kim SJ; Cho HJ; Hong SH; Lee JY; Hwang TK; Kim SW
    Lasers Med Sci; 2015 May; 30(4):1387-93. PubMed ID: 25833318
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years.
    Sievert KD; Schonthaler M; Berges R; Toomey P; Drager D; Herlemann A; Miller F; Wetterauer U; Volkmer B; Gratzke C; Amend B
    World J Urol; 2019 Jul; 37(7):1353-1360. PubMed ID: 30283994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.